PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WARREN, N.J., Sept. 25, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on Sept. 22, 2026, the company approved non-statutory stock options to purchase an aggregate of 51,270 shares of its common stock and 37…

Summary from PR Newswire - Clinical Trials.

Coverage 1 article · 1 outlet

1. PR Newswire - Clinical Trials 28m ago
   PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) ↗